1.
Detection of Urokinase-type Plasminogen Activator Receptor and Its Clinical Significance in Cervical Cancer;
宫颈癌患者尿激酶受体的检测及其临床意义
2.
Detection of Urokinase-type Plasminogen Activator Receptor and its Clinical Significance in Lung Cancer;
肺癌患者尿激酶受体的检测及其临床意义
3.
Detection of the receptor for urokinase-type plasminogen activator and its clinical application;
尿激酶受体检测方法的建立及其临床应用
4.
Study on the Expression and Correlation of uPAR、Cathepsin D、nm23 in Gastric Cancer;
胃癌组织中尿激酶受体、组织蛋白酶D和nm23的表达及其相关性研究
5.
Construction and identifi cation of specifi c shRNA interference plasmid vector targeted to uPAR gene
靶向尿激酶受体uPAR基因的shRNA表达载体的构建及鉴定
6.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
7.
Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
8.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
9.
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
10.
Association between Peroxisome Proliferator-activated Receptor γ Coactivator-1 Gene and Type 2 Diabetes Mellitus of Chinese;
过氧化物酶增殖体受体γ协同刺激因子-1与2型糖尿病的关系
11.
Gene expression and significance of urokinase type plasminogen activator and its receptor in oral and maxillofacial tumor tissue
口腔颌面部恶性肿瘤尿激酶及其受体的基因表达和临床意义
12.
Significance of Urokinase-type Plasminogen Activator and Urokinase-type Plasminogen Activator Receptor in Synovial Fluid of Patients with Temporomandibular Disorders;
颞下颌关节紊乱病关节液中尿激酶型纤溶酶原激活物及其受体的检测
13.
Detection and clinical significance of plasma urokinase-type plasminogen activator and its soluble receptor in multiple myeloma patients;
多发性骨髓瘤患者血浆尿激酶型纤溶酶原激活物及其可溶性受体的检测
14.
The Relationship of LN-R and uPA in Invasive Ductal Breast Cancer
层粘连蛋白受体、尿激酶型纤溶酶原激活物在乳腺浸润性导管癌中的表达及其相关性
15.
Expressions of liver X receptor,11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor in the liver of streptozotocin-induced diabetes rat
糖尿病大鼠肝X受体、11β-羟基类固醇脱氢酶和糖皮质激素受体表达的改变
16.
The Construction and Characterization of Human Prourokinase Mutant;
人尿激酶原突变体的构建与特性分析
17.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
18.
The Association of Peroxisome Proliferator-activ Ated Receptor-γ2 Gene Pro12Ala Polymorphism with Type 2 Diabetes Mellitus;
过氧化物酶体增殖物激活受体γ2基因Pro12Ala多态与2型糖尿病关系的研究